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Abstract
Akt, a serine/threonine kinase has been shown to stimulate glycolysis in cancer cells but its role in mitochondrial respiration
is unknown. Using PTEN-knockout mouse embryonic fibroblasts (MEFPTEN2/2) with hyper-activated Akt as a cell model, we
observed a higher respiratory capacity in MEFPTEN2/2 compared to the wildtype (MEFWT). The respiratory phenotype
observed in MEFPTEN2/2 was reproduced in MEFWT by gene silencing of PTEN which substantiated its role in regulating
mitochondrial function. The increased activities of the respiratory complexes (RCs) I, III and IV were retained in the same
relative proportions as those present in MEFWT, alluding to a possible co-ordinated regulation by PTEN/Akt. Using LY294002
(a PI3K inhibitor) and Akt inhibitor IV, we showed that the regulation of enzyme activities and protein expressions of the RCs
was dependent on PI3K/Akt. There was insignificant difference in the protein expressions of mitochondrial transcription
factor: peroxisome proliferator-activated receptor gamma coactivator 1-alpha (PGC-1a) and its downstream targets, the
nuclear respiratory factor 1 (NRF-1) and mitochondrial transcription factor A (mtTFA) between MEFPTEN2/2 and MEFWT.
Similarly, mRNA levels of the same subunits of the RCs detected in Western blots were not significantly different between
MEFPTEN2/2 and MEFWT suggesting that the regulation by Akt on mitochondrial function was probably not via gene
transcription. On the other hand, a decrease of total 4E-BP1 with a higher expression of its phosphorylated form relative to
total 4E-BP1 was found in MEFPTEN2/2, which inferred that the regulation of mitochondrial respiratory activities by Akt was
in part through this protein translation pathway. Notably, gene silencing of 4E-BP1 up-regulated the protein expressions of
all RCs and the action of 4E-BP1 appeared to be specific to these mitochondrial proteins. In conclusion, PTEN inactivation
bestowed a bioenergetic advantage to the cells by up-regulating mitochondrial respiratory capacity through the 4E-BP1-
mediated protein translation pathway.
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Introduction
PTEN (phosphatase and tensin homology deleted on chromo-
some 10) is one of the tumor suppressors frequently lost in cancers
[1,2]. It has both protein and lipid phosphatase activities; the latter
is associated with tumor suppression [3,4]. By dephosphorylating
phosphatidylinositol-3,4,5-trisphosphate (PIP3), PTEN prevents
the membrane recruitment and activation of Akt which promotes
cell survival, proliferation, growth and glycolysis [5,6]. The ability
of Akt in stimulating cell proliferation is best illustrated in Cowden
and other PTEN hamartoma tumor syndromes [7]. The benign
nature of these tumors could be due to the fact that neither PTEN
nor Akt alone is sufficient for the cell to become cancerous [8,9].
The signaling downstream of Akt is integrated by mTOR
(mammalian target of rapamycin) and transduced to ribosomal
protein kinase S6 kinase (S6K) and the eukaryotic translation
initiation factor 4E (eIF4E)-binding proteins (4E-BP1, 2 and 3) to
regulate protein translation [10]. 4E-BP1 is a repressor of 59cap-
dependent mRNA translation and it is inactivated upon
phosphorylation by mTORC1. The phosphorylated 4E-BP1 is
then released from the eukaryotic initiation factor 4E (eIF4E)
which subsequently binds eIF4G to begin protein translation [11].
4E-BP1 is a key effector of oncogenic activation of the Akt and
ERK signaling pathways that integrate their function in tumors
[12]. It correlates with the clinical findings that expression of high
level of phosphorylated 4E-BP1 is associated with poor prognosis
in several types of tumor, independent of the alteration of
upstream oncogenic signaling [13].
While the activation of Akt by defective respiration in cancer
cells has been shown to stimulate aerobic glycolysis [14,15], the
action of Akt on the mitochondrial respiration in cell transforma-
tion remains largely unknown. In this study, MEFWT and
MEFPTEN2/2 were used as a model to examine if the PTEN/
Akt pathway has an effect on oxidative metabolism in normal and
transformed cells. We compared a number of mitochondrial
parameters and found that the MEFPTEN2/2 with hyper-activated
Akt exhibited higher enzyme activities and protein expressions of
all respiratory complexes. Pre-treatment of MEFPTEN2/2 with
LY294002 (LY), an inhibitor of PI3K and mTOR [16] and Akt
inhibitor IV decreased (a) the phosphorylation of Akt at both
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Ser473 and Thr308, (b) the phosphorylation of 4E-BP1 at Thr37/46
and (c) the expressions of RC I, III and IV. We also measured the
mRNAs of the same subunits of the RCs detected in Western blots
and the protein expressions of the peroxisome proliferator-
activated receptor gamma coactivator 1-alpha (PGC-1a), the
nuclear respiratory factor 1 (NRF-1) and mitochondrial transcrip-
tion factor (mtFTA) and showed that the regulation of mitochon-
drial function by Akt was probably not dependent on transcrip-
tion. In conclusion, the higher proliferation in MEFPTEN2/2 was
accompanied by increased mitochondrial respiratory capacity.
The protein expressions of the RCs in MEFPTEN2/2 are
attenuated by LY294002 and Akt inhibitor IV but are increased
in MEFWT by siRNA targeting PTEN or 4E-BP1, suggesting a
regulation of mitochondrial respiratory activities by the PTEN/




The MEFWT and MEFPTEN2/2 cell lines [6] were kindly
provided by Dr. Tak W. Mak of University of Toronto. They were
cultured in DMEM (Sigma, D1152) with 100 U/ml penicillin,
100 mg/ml streptomycin, 2 mM glutamine and 10% fetal bovine
serum in 5% CO2 at 37uC.
Respiratory flux
The measurement of respiratory flux in intact MEF cells in a
high-resolution respiratory system (Oroboros, Oxygraph-2k) was
carried out according to the protocol described [17]. Cellular
routine (R) state was established with the presence of cells in 2 ml
of culture medium in the chamber at 37uC with constant stirring
for 15–30 min. In the absence of exogenous substrates, the R
(routine) respiration is dependent on endogenous substrates and
substrates present in the culture medium. Following the stabiliza-
tion of R, oxygen consumption is measured in the presence of
2 mg/ml oligomycin to obtain the Leak (L) state. In this non-
physiological state, L respiration reflects intrinsic uncoupling of the
mitochondria. Subsequently, a maximal electron transport system
capacity (E) of the mitochondria is achieved by titrating
sequentially with repeated doses of 1 ml from 1 mM FCCP until
a maximal response is achieved. The net Routine/E is then
calculated by applying the formula: Net routine/E= (R2L)/E.
This parameter therefore represents the net oxygen consumption
coupled to ATP biosynthesis, taking into account the leak
component.
Isolation of mitochondria
The procedure described in [18] was used with slight
modifications. Cells were trypsinized, centrifuged at 1000 g for
5 min and the pellet was re-suspended in 1 ml of medium
containing 250 mM sucrose, 20 mM Hepes, 10 mM KCl,
1.5 mM MgCl2, 1 mM EDTA and 1 mM EGTA, pH 7.4. This
was followed by homogenization with 40 up-and-down strokes
using a hand-held glass pestle. The mixture was then centrifuged
at 800 g for 10 min and the supernatant obtained was subjected to
another step of centrifugation at 14,000 g for 15 min. The final
pellet was re-suspended in the same medium and was used
immediately for ATP biosynthesis and measurement of MMP or
kept at 280uC as freeze-thawed mitochondrial extracts for other
enzyme assays.
ATP biosynthesis
ATP production in 5 min was measured from the oxidation of
the following substrates 6 inhibitor: 10 mM succinate+5 mM
rotenone, 5 mM each malate/glutamate, or 5 mM ascorbate and
1 mM tetramethylphenylenediamine (TMPD)+2 mg/ml antimycin
A. 125 mM ADP and 30 mg mitochondrial protein were used in
the reaction which was stopped by placing the tubes in a heating
block at 100uC for 3 min, followed by centrifugation at 14,000 g
for 15 min. ATP formed was measured by the luciferin/luciferase
reaction and the luminescence produced was read in a luminom-
eter (Victor 3, Perkin-Elmer) as described previously [19,20].
Measurement of mitochondrial membrane potential
(MMP)
The membrane potential was measured in isolated mitochon-
dria using JC-1, a specific mitochondrial probe, by a change in the
ratio of red fluorescence of the J-aggregates to that of the green
fluorescence of its monomers at Ex/Em wavelengths of 485/
595 nm and 485/535 nm, respectively. Routinely, 0.2 mM JC-1,
125 mM ADP and 0.5 mg of mitochondrial protein were used with
the following added sequentially: 5 mM each glutamate/malate,
5 mM rotenone; 10 mM succinate and 10 mM malonate.
Activities of tricarboxylic acid cycle (TCA) enzymes
Assay conditions for measuring citrate synthase (CS) malate
dehydrogenase (MDH) and glutamate dehydrogenase (GDH) in
the freezed-thawed mitochondrial extracts have been described
previously [21].
NADH dehydrogenase or RCI
The enzyme activity of RCI was measured by a decrease in
fluorescence of NADH in 5 min at excitation wavelength 352 nm
and emission wavelength 464 nm using decylubiquinone as an
electron acceptor [22]. A mitochondrial extract containing 20 mg
protein was added to a respiratory buffer of pH 7.2 containing
25 mM KH2PO4, 2 mM NaN3, 5 mM MgCl2, 64 mM decylubi-
quinone, 2 mg/ml albumin and 25 mM NADH.
Succinate dehydrogense or RCII
The assay was based on a decrease in absorbance of 2,6-
dichlorophenolindolephenol (DCPIP) at 600 nm monitored for
5 min, with decylubiquinone as an acceptor [23]. A mitochondrial
extract containing 30 mg protein was employed in the presence of
1 mM rotenone, 2 mg/ml antimycin A and 2 mM NaN3 to inhibit
RCI, III and IV, respectively. A pre-incubation with succinate was
carried out at 37uC for 5 min with the mitochondrial extract to
overcome the known inhibitory effect of oxaloacetate on RCII.
Ubiquinol dehydrogenase or RCIII
This activity was measured by a coupled assay using reduced
decylubiquinone and cytochrome c (cyt c) as described [24]. The
assay was started by adding 50 mM cyt c to a buffer containing
250 mM sucrose, 1 mM EDTA and 50 mM Tris-HCl, pH 7.4
and 30 mg mitochondrial protein. The absorbance of reduced cyt c
was followed for 5 min at 550 nm.
Cytochrome c oxidase or RCIV
The assay measured the rate of decrease of reduced cyt c as
reported previously [25]. Cyt c was first reduced by adding 4 mg
ascorbate to 10 mg/ml cyt c. The reaction was started by adding
80 mg mitochondrial protein to a solution containing 4 mM
KH2PO4 and reduced cyt c. The decrease in absorbance of
reduced cyt c was followed at 550 nm for 20 sec.
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FoF1-ATPase or RCV
This was measured by coupling the ADP formed to pyruvate
kinase using phosphoenolpyruvate as the substrate. Pyruvate
formed was reduced to lactate by lactate dehydrogenase (LDH) as
described previously [25,26]. The decrease in NADH was
monitored for 10 min at 340 nm in an absorbance microplate
reader.
Determination of mitochondrial protein
The protein concentrations of the mitochondrial fraction and
the whole cell lysate prepared from MEFWT and MEFPTEN2/2
were determined by the bicinchoninic acid assay [27]. The purity
of the mitochondrial fraction was examined by Western blot
analysis using the mitochondrial and cytosolic markers, voltage
dependent anion channel (VDAC) and Cu-Zn superoxide
dismutase (SOD-1), respectively.
Western blot analysis
Aliquots of the mitochondrial or cytosolic fractions or total cell
lysates containing 50 mg protein were subjected to electrophoresis
on sodium dodecyl sulfate-polyacrylamide gel and electro-blotted
onto a nitrocellulose membrane. After blocking with 10% non-fat
milk in TBS with 0.1% Tween-20, the membranes were probed
with the respective primary antibodies of PTEN, Akt, p-Ser473Akt,
p-Thr308Akt, 4E-BP1, p-Thr37/46 4E-BP1, B-cell lymphoma 2
(Bcl-2) (Cell Signaling Technology, Beverly, MA, USA), VDAC
(Calbiochem, San Diego, CA, USA) malic enzyme 1 (ME 1),
hexokinase II (HK II), pan-actin (product no. sc-1615), PGC-1 a,
NRF-1, mtTFA, SOD-1 (Santa Cruz Biotechnology, CA, USA),
lactate dehydrogenase isoenzyme V (LDH-V) (Abcam, Cam-
bridge, UK), uncoupling protein 2 (UCP2) (Alpha Diagnostic,
Texas, USA), a-tubulin (Sigma-aldrich, St. Louis, MO, USA) and
aconitase 2 (ACO2) (Abgent, San Diego, CA USA). Western blot
analysis of the respiratory complexes was carried out using a
cocktail containing antibodies against the following subunits of the
five RCs: complex I subunit NDU FB8, complex II subunit
30 kDa (SdhB), complex III subunit Core 2 (RC III core 2),
complex IV subunit I (CO1) and ATP synthase a-subunit (ATP5
F1a1) (MitoSciences, Oregon, USA). All primary antibodies were
used at a dilution of 1:1000 except for a-tubulin and pan-actin, the
loading controls, which were diluted 1:20000. Anti-goat pan-actin
was used as the loading control for the Western blot analysis of the
respiratory complexes because the a-subunit of ATP synthase and
a-tubulin of same species (mouse) have similar molecular weight
and therefore could not be resolved.
Inhibition by LY294002 and Akt inhibitor IV
Briefly, MEFPTEN2/2 grown to 70% confluence were pre-
incubated with either 25 mM LY for 4 h or 1 mM Akt inhibitor IV
for 8 h prior to enzymatic assays and Western blot analyses.
RNA extraction and reverse transcription
Total RNA from MEFWT and MEFPTEN2/2 was isolated using
TRIzol reagent (Invitrogen, Carlsbad, CA, USA) according to the
manufacturer’s instructions. 500 ng RNA was reverse transcribed
using 1 ml of ImPromII reverse transcriptase and 0.5 mg random
hexamer for 60 min at 42uC and terminated at 70uC for 5 min
according to the instruction from the manufacturer (Promega,
Madison, WI, USA).
Primers and real-time PCR
The mRNAs of the same five RC subunits detected in Western
blot analyses were quantified by real-time PCR by using their
respective forward and reverse primers as shown in Table S1. The
mRNA of 4E-BP1 was detected using forward primer: 59-
GGACCAGCCGTAGGAC-39, reverse primer: 59-TGAGT-
GAGGAGCAGGAC-39. Mouse alpha 1A tubulin (forward
Figure 1. Characterization of MEFPTEN2/2. (A) Western blot
analyses of PTEN, Akt, p-Ser473Akt and p-Thr308Akt Immunoblotting of
PTEN, Akt, p-Ser473Akt and p-Thr308Akt was carried out on whole cell
lysates of MEFWT and MEFPTEN2/2. The loss of PTEN in MEFPTEN2/2
resulted in hyperactivation of Akt on both phosphorylation sites
without affecting the expression of total Akt. The respective loading
controls of a-tubulin were included. (B) Rate of cell proliferation This was
measured by the trypan-blue exclusion assay. The MEFPTEN2/2 has a
significantly higher rate of proliferation compared to MEFWT from days
1–4 of culture. # p,0.005 for n = 3.
doi:10.1371/journal.pone.0045806.g001
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Figure 2. Mitochondrial parameters in MEFWT and MEFPTEN2/2. (A) Biosynthesis of ATP This was carried out in isolated mitochondria which
showed a higher rate of ATP generation in MEFPTEN2/2 compared to MEFWT. The respiratory substrates (6 inhibitor) were 5 mM each of malate/
glutamate (M/G), 10 mM succinate+5 mM rotenone, and 1 mM TMPD and 5 mM ascorbate in the presence of 2 mg/ml antimycin A. * p,0.05, #
p,0.005 for n = 3. (B) Mitochondrial membrane potential The cationic dye, JC-1was used to monitor the mitochondrial membrane potential (MMP). JC-
1 monomers (green fluorescence) form J-aggregates (red fluorescence) in the matrix upon energization by added respiratory substrates namely
PTEN/Akt/4E-BP1 and Mitochondrial Respiration
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primer: 59-TCGATGAAGTTCGCACCG-39, 59-reverse primer:
TATTGGCAGCATCCTCCT-39) was used as an internal
control for normalization. Real time PCR using SYBR Green I
was performed on the iCycler iQ (Biorad, Hercules, CA, USA) in a
total volume of 25 ml containing 16 Xtensa-Mix-SG (Bio-
WORKS, Singapore), 1 ml of cDNA sample, 2.5 mM MgCl2,
0.2 mM of each primer, and 0.5 U KlearTaq DNA polymerase
(KBiosciences, Hertfordshire, UK). Real-time PCR was carried
out after an initial denaturation of 10 min at 95uC followed by 40
cycles of 20 s denaturation at 95uC, 20 s annealing at 60uC and
20 s extension at 72uC. Detection of fluorescence was carried out
at the annealing phase. The threshold cycles (Ct) were calculated
automatically using the iQ5 software (Bio-Rad).
SiRNA targeting PTEN and 4E-BP1
Gene silencing of PTEN on MEFWT and of 4E-BP1 on both
MEFWT and MEFPTEN2/2 were carried out using small
interference RNAs. Cells at 60–70% confluence were transfected
for 16 h with either (a) 20 nM PTEN (sense: CGAUCUUGA-
CAAAGCAAACtt, antisense: GUUUGCUUUGUCAA-
GAUCGtt purchased from Ambion, NY) or (b) with 4E-BP1-
targeting RNA which consists of a pool of 3 target-specific 4E-BP1
siRNAs (product no. sc-29595 from Santa Cruz Biotechnology,
CA, USA) or (c) with non-targeting RNAs r(UUCUCCGAAC-
GUGUCACGU)d(TT) and r(ACGUGACACGUUC GGA-
GAA)d(TT) from Qiagen, Hilden, Germany. Following 18 h of
recovery in normal culture medium, the efficiency of knockdown
of PTEN and 4E-BP1, the effects of PTEN and 4E-BP1
knockdown on RC expressions and the effect of PTEN knockdown
on respiratory flux were measured.
Statistical Analysis
Data were presented as means 6 SD, and were analyzed by the
Student’s t-test where a p value of ,0.05 was considered
significant.
Results
Characterization of MEF PTEN2/2
We first confirmed the PTEN knockout phenotype in
MEFPTEN2/2 by immunoblotting the protein expressions of
PTEN, total and phospho-Akts in the whole cell lysate. The
absence of PTEN causing Akt hyperactivation was evident by the
higher expressions of p-Ser473Akt and p-Thr308Akt without a
significant change in the total Akt (Fig. 1A). In the absence of
PTEN, a significantly higher rate of proliferation was observed in
MEFPTEN2/2 from day 1 to 4 (Fig. 1B) with a doubling time of
22 hr and 16 hr, respectively, for MEFWT and MEFPTEN2/2
(data not shown).
Oxidative phenotype in MEF PTEN2/2
ATP biosynthesis. The overall function of mitochondria in
energy production was measured by the rate of ATP biosynthesis
in isolated intact mitochondria upon the addition of respiratory
substrates. As shown in Fig. 2A, the rate of ATP biosynthesis from
the oxidation of malate/glutamate for RCI, succinate for RCII
and TMPD/ascorbate for RCIV was significantly higher in
MEFPTEN2/2 compared to the MEFWT.
Mitochondrial Membrane potential (MMP). The gener-
ation of mitochondrial membrane potential is often used as an
indicator to assess mitochondrial respiratory function. We
measured the MMP of intact mitochondria using the JC-1 dye
with serial addition of substrates and inhibitors. The uptake of JC-
1, a cationic dye, depends essentially on the MMP. The oxidation
of respiratory substrates such as malate/glutamate and succinate
added to mitochondria induced the generation MMP, resulting in
an increased entry of JC-1 monomers which exhibited a green
fluorescence. With enhanced accumulation, the monomers com-
bined to form J-aggregates which showed a red fluorescence. The
ratio of red:green fluorescence measured the magnitude of the
MMP. The MMP induced by malate/glutamate and succinate
was higher in the MEFPTEN2/2 compared to MEFWT as shown in
Fig. 2B. Inhibition of RCI by rotenone and of RCII by malonate
confirmed the measurement and functionality of RCI and RCII.
Respiratory Flux. To investigate the effect of PTEN/Akt on
mitochondrial function, oxygen consumption was measured with
intact cells in normal culture medium. As compared to isolated
mitochondria, the intact cell analysis allowed an integration of
regulatory events by which cytoplasmic and nuclear factors
influenced mitochondrial function. Net R/E (where R=Routine
and E=ETS) combined basal oxygen consumption (Routine),
oligomycin-inhibited respiration (Leak) and maximal capacity of
electron transport system (E) to provide a parameter R/E which
measured the proportion of respiratory capacity coupled to
oxidative phosphorylation. As shown in a representative set of
data for MEFPTEN2/2 and MEFWT (Fig. 2C), the former had
higher Net Routine/E, which inferred that a higher proportion of
oxygen consumption of the electron transport system was coupled
to ATP synthesis. This could be contributed by a lower degree of
leak respiration, expressed as Leak/E as shown in Fig. 2C inset,
which was obtained from three independent experiments.
Activities and protein expressions of respiratory
complexes. The higher MMP and rate of ATP biosynthesis
in MEFPTEN2/2 observed above suggested a possible increase in
the electron transport system coupled to the phosphorylation of
ADP. This was reflected in the data of respiratory flux above.
Indeed, extracts of mitochondria isolated from MEFPTEN2/2
showed higher activities of all five respiratory complexes compared
to the MEFWT (Fig. 2D). Interestingly, the ratios of RC III/I, IV/
I, and IV/III in the MEFPTEN2/2 were similar in magnitude to
malate/glutamate (M/G, 5 mM each) and succinate (10 mM). Rotenone (5 mM) and malonate (10 mM), inhibitors of RCI and II, respectively, decreased
the MMP as reflected by an attenuation of the ratio of red:green fluorescence. Mitochondrial protein used was 0.5 mg. Data presented is representative
of 3 independent experiments. (C) Oxygen consumption The NetR/E (where R=Routine and E=maximal electron transport system capacity) was
obtained as described under ‘‘Experimental procedures’’ using an Oxygraph 2k (Oroboros). A higher NetR/E was observed in MEFPTEN2/2 compared to
MEFWT as shown in a representative set of data. On the other hand, Leak/E was always lower in MEFPTEN2/2. A significant difference in NetR/E between
the two cell lines showed that the electron transport system was more efficient in driving ATP synthesis in MEFPTEN2/2 compared to MEFWT as shown in
Fig. 2C inset; the latter was based on three independent sets of experiments with ** p,0.01 for n= 3. (D) Enzyme activities of the RCs These were
expressed in nmol/min/mg protein. They were measured as described in the ‘‘Experimental procedures’’. Ratios of RC III/I, IV/I and IV/III are shown in the
inset. * p,0.05, # p,0.005 for n= 3. (E) Western blot analyses of respiratory complexes Whole cell lysates of MEFWT and MEFPTEN2/2were probed with a
cocktail containing antibodies against various subunits of the five RCs as described in the text. Quantification of the bands by the ImageJ software
showed% increase in protein expressions of RCs in MEFPTEN2/2 relative to MEFWT. A higher degree of increase in RCI, III and IV, as compared to RCII and V
was apparent (Fig. 2E inset). (F) Activities of TCA cycle enzymes Glutamate dehydrogenase (GDH), malate dehydrogenase (MDH) and citrate synthase (CS)
were measured in freeze-thawed mitochondrial extracts as described in [21]. # p,0.005. for n = 3.
doi:10.1371/journal.pone.0045806.g002
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those in the MEFWT (Fig. 2D, inset). This observation alluded to a
coordinated regulation of these RCs via transcription, translation
and/or post-translation. At the protein level, we observed higher
expressions of all five RCs in the MEFPTEN2/2 compared to the
MEFWT (Fig. 2E). Quantification of the bands using the ImageJ
software showed a significant difference based on triplicate
measurements and a higher magnitude of increase in RCI, III
and IV compared to RCII and V (Fig. 2E inset).
Tricarboxylic acid (TCA) cycle enzymes. To sustain a
higher MMP and rate of ATP biosynthesis, more reducing
equivalents must be fed into the electron transport system from the
TCA cycle. We found the activities of glutamate dehydrogenase
(GDH) and malate dehydrogenase (MDH), two NAD-linked
enzymes as well as citrate synthase (CS), a mitochondrial marker
enzyme, were significantly higher in the MEFPTEN2/2 as
compared to the MEFWT (Fig. 2F).
Enhanced mitochondrial function in MEFPTEN2/2
(a) Akt hyperactivation. A significantly higher protein
expression of all RCs was found in MEFWT with siRNA
knockdown of PTEN (Fig. 3A and inset). The PTEN-knockdown
cells exhibited higher Net R/E with lower Leak/E (Fig. 3B),
suggesting that PTEN aberration could be responsible for the
enhanced coupling between oxidation and phosphorylation in
mitochondria isolated from MEFPTEN2/2 (shown previously as
NetR/E in Fig. 2C). To further explore if the higher mitochon-
drial respiration in MEFPTEN2/2 was attributed to hyperactivated
Akt, inhibition of the PI3K/Akt signaling pathway was attempted
with LY294002, known to act on PI3K and mTOR [16,28,29]
and Akt Inhibitor IV, an ATP-competitive inhibitor of Akt
autokinase activity [30]. Both inhibitors reduced the phosphory-
lation at Ser473 and Thr308 of Akt without affecting the total Akt
(Fig. 4A and 4B). The reduction in Akt phosphorylation by these
two inhibitors correlated with (a) decreased enzyme activities of all
four electron-transport complexes (I to IV) in MEFPTEN2/2
(Table 1) and (b) repression of the protein expressions of RCI, III,
and IV (these are involved in proton pumping) in MEFPTEN2/2
(Fig. 4C and 4D). The protein expressions of RCII and V were not
or minimally affected.
(b) Regulation of gene transcription. The peroxisomal
proliferator activated receptor c coactivator-1a (PGC-1a) and its
downstream targets: nuclear respiratory factor-1 (NRF-1) and
mitochondrial DNA transcription factor A (mtTFA) are known to
enhance respiratory function by acting on several nuclear genes
encoding subunits of the respiratory complexes [31,32]. The level
of these proteins could provide some indication if transcriptional
regulation played a role in the Akt-mediated up-regulation of
mitochondrial activities observed in MEFPTEN2/2. No significant
difference was observed in their protein expressions (Fig. 5A and
inset). Similarly, the mRNA levels of the five subunits of
respiratory RCs used in our Western blot analysis were not
significantly different between MEFPTEN2/2 and MEFWT (Fig. 5B
and inset). Together, these sets of data suggested that the increased
expressions of the RCs observed in MEFPTEN2/2 were not likely
to be dependent on gene transcription.
(c) 59 cap-dependent protein translation. We next ex-
plored if the Akt-mediated mitochondrial function was regulated
by protein translation. As mentioned previously, 4E-BP1 has a
central role in converging the upstream signals to protein
translation [12,13]. Comparatively, MEFPTEN2/2 had lower 4E-
BP1 (Fig. 6A) and a higher proportion of p-Thr37/464E-BP1
relative to total 4E-BP1 when compared to MEFWT (Fig. 6A,
inset). The mRNA levels of 4E-BP1 in the two cell types were not
significantly different (p = 0.148) as shown in Fig. 6B. In addition,
the repression of activities and expressions of the RCs by
LY294002 and Akt inhibitor IV could also be mediated by 4E-
BP1 as incubation with LY294001 resulted in a band shift
downwards in total and p-4E-BP1 (shown by arrows in Fig. 6C), a
phenomenon which indicated hypo-phosphorylation [11]. Al-
though there was no band shift with Akt inhibitor IV, there was
evidence of a more hypo-phosphorylated p-Thr37/46 4E-BP1 and
total 4E-BP1 (shown by arrows of lower bands of greater intensity
Figure 3. RNA-silencing PTEN in MEFWT. (A) Western blot analyses
of respiratory complexes The protein expressions of all five RCs were
significantly up-regulated by si-RNA of PTEN. A higher degree of
increase in RCI, III and IV, as compared to RCII and V was apparent
(inset). (B) Oxygen consumption si-RNA of PTEN was accompanied by an
increase in the net oxygen consumption expressed as NetR/E and a
decreased Leak/E when compared to untreated MEFWT. * p,0.05, #
p,0.005 for n = 3.
doi:10.1371/journal.pone.0045806.g003
PTEN/Akt/4E-BP1 and Mitochondrial Respiration
PLOS ONE | www.plosone.org 6 September 2012 | Volume 7 | Issue 9 | e45806
in Fig. 6D). In general, hypo-phosphorylation of 4E-BP1 and/or
p-Thr37/46 4E-BP1 would lead to decreased protein translation
which was evident in RC I, III and IV expressions in MEFPTEN2/
2 following inhibition by LY and Akt inhibitor IV (Figs. 4C and
4D). Gene silencing of 4E-BP1 in MEFWT and MEFPTEN2/2 up-
regulated the expressions of all RCs (Fig. 6E and 6F, respectively).
The fact that this was also observed in MEFPTEN2/2 suggested
that there was residual 4E-BP1 in these cells which was
demonstrated in Fig. 6A. The higher degree of increase in RC
expressions in the MEFWT by si-4E-BP1 (Fig. 6E) could be
explained by their higher basal 4E-BP1 (Fig. 6A). A number of
other assorted proteins were also measured following si-4E-BP1,
but their protein expressions were not significantly changed,
except for Bcl-2 which was down regulated (Figure S1).
(d) Direct control of RC expressions by 4E-BP1. To
examine if 4E-BP1 exerts control directly downstream of Akt
activation, we performed gene silencing on 4E-BP1 in MEFWT
followed by inhibition with Akt inhibitor IV. As shown in Fig. 6G,
si-RNA of 4E-BP1 up-regulated all the RC expressions in the
absence or presence of Akt inhibitor IV (Lanes 2 and 3) as
Figure 4. Effects of LY294002 and Akt inhibitor IV on MEFPTEN2/2. MEFPTEN2/2 were exposed to 25 mM LY294002 for 4 h or 1 mM Akt
inhibitor IV for 8 h. (A, B) Western blot analyses of p-Ser473Akt, p-Thr308Akt and total Akt Expressions of p- Ser473Akt, p-Thr308Akt were compromised by
LY and Akt inhibitor IV, respectively, while total Akt remained relatively unchanged. (C, D) Western blots of respiratory complexes Protein expressions
of respiratory complexes I, III and IV were down regulated by LY and Akt inhibitor IV. Those of RCII and RCV appeared to be unaffected.
doi:10.1371/journal.pone.0045806.g004
PTEN/Akt/4E-BP1 and Mitochondrial Respiration
PLOS ONE | www.plosone.org 7 September 2012 | Volume 7 | Issue 9 | e45806
compared to untreated controls (Lane 1), indicated by *p,0.05
and #p,0.005. In other words, with gene silencing of 4E-BP1, the
RC expressions were not affected by Akt inhibition as shown by
p.0.05 in Fig. 6G inset. However, when 4E-BP1 was intact (Lane
4), inhibition of Akt down-regulated RC expressions. This positive
control showed the efficiency of the Akt inhibitor IV, which has
previously been demonstrated in MEFPTEN2/2 (Fig. 4D). To-
gether, the results suggested that regulation of RC expressions by
Akt was dependent on 4E-BP1.
(e) Increased mitochondrial protein relative to total
protein. In view of the mitochondrial location of the RCs, it
was conceivable that their up-regulation could contribute to more
proteins in this organelle relative to the total cellular protein in
MEFPTEN2/2. Indeed, we observed a three-fold increase in the
ratio of mitochondrial protein relative to total cellular protein in
MEFPTEN2/2 compared to MEFWT (Fig. 6H). The purity of the
mitochondrial preparation was confirmed by the use of SOD-1
and VDAC, the cytosolic and mitochondrial markers respectively
(Fig. 6H, inset).
Discussion
The immortalized MEFPTEN2/2 [6] provided a cell model to
study any aberrant metabolism resulting from the oncogenic
action of Akt. Following its activation, Akt has been reported to
translocate to the mitochondria to act on its downstream targets
[33]. Thus, there is evidence of a cross-talk between Akt and
mitochondria. This study explores if Akt hyperactivation has an
impact on mitochondrial metabolism. It is conceivable that
accelerated aerobic glycolysis from Akt signaling [14] produces
increased pyruvate which is channeled concomitantly to lactate
and the TCA cycle. The reducing equivalents, NADH and
FADH2 generated in the mitochondrial matrix are finally oxidized
by the active electron transport system consisting of up-regulated
RCs in MEFPTEN2/2. These could contribute to the higher MMP
and ATP biosynthesis in MEFPTEN2/2 and increased oxygen
consumption reported in Akt-transfected MEFs [34]. Our study
also showed consistently higher net routine oxygen consumption in
MEFPTEN2/2 which was reproducible by silencing PTEN in the
wild type. In both instances, the lower degree of leak respiration
may lead to their greater efficiency in OXPHOS. Lower leak is
possibly the result of their higher cholesterol content as we had
noted consistently that 2–3 times more digitonin was required for
cell permeabilization of MEFPTEN2/2. It has been reported that
cholesterol enhances the rigidness of mitochondrial membranes
leading to a lower leak [35]. In addition, higher enzyme activities
of the RCs could be another contributing factor. Of particular
interest is that the MEFPTEN2/2 retain similar relative proportions
of activities of RCI, III and IV as those present in the wild type
which infers that they could be co-ordinately regulated. These
three RCs form supercomplexes known as respirasomes [36,37]
which may subject them to collective regulation. Our ratio of the
enzyme activities of 1:2 for RCIII: RCIV is coincidentally similar
to that deduced in the model of the ‘‘respiratory string’’ which is
made up of several respirasomes [37].
Two inhibitors of the Akt/mTOR pathway were used to
examine if the higher RC activities and expressions were
attributed to hyperactivated Akt from PTEN aberration in
MEFPTEN2/2. They are LY294002 (LY) which targets both
PI3K and mTOR [16,28,29] and Akt inhibitor IV which has
previously been reported to block Akt autokinase activity [30].
Both inhibitors decreased RC enzyme activities and protein
expressions of RC I, III, and IV, with little to no change in RCII
and RCV, an observation which further supports the concept of
organization of these three proton pumping RCs in super-
complexes of respirasomes discussed above [37]. In addition to
their co-ordinated regulation, their ease of change could be
explained by their different values of DG of folding energy and the
length of the 59UTRs [38]. RC IV with a DG of 27Kcal/mol and
short 59UTRs could render it more amendable to inhibition and
possibly transcription and/or translation in contrast to RCV with
a DG of 246Kcal/mol which would be more resistant to change
as towards LY and Akt inhibitor in this study. Overall, LY seems
to exert a greater influence on these reactions as it is an inhibitor of
both PI3K and mTOR [16,28,29]. Inhibition of mTORC2 by LY
would compromise the phosphorylation of Ser473 and the
subsequent phosphorylation at Thr308 of Akt necessary for its full
activation [39]. In addition, its inhibition of mTORC1 would have
a more direct impact on 4E-BP1 as compared to Akt inhibitor IV
which acts upstream. However, the greater effect of LY did not
result in a more pronounced inhibition of RC enzyme activities.
This may suggest that RC activities are more directly affected by
Akt kinase since the Akt inhibitor IV has been reported to
compromise the Akt autokinase activity more significantly than
wortmanin, another PI3K inhibitor [30]. No attempt is made to
correlate the degree of inhibition of enzyme activities with protein
expressions of the RCs as Western blot analysis depends on only
one of several subunits present in the RC, whereas enzyme activity
measures the functionality of the composite RC. A differential
mechanism of action of the two inhibitors was also inferred from
the distinct band shifts in 4E-BP1 and its phosphorylated form by
LY which was not apparent with Akt inhibitor IV.
Although our data of LY and Akt inhibitor IV described above
provide a plausible relationship between Akt, 4E-BP1 and RC
expressions, siRNA targeting 4E-BP1 is deemed necessary to
establish unequivocally a direct association between 4E-BP1 and
RC expressions. In eukaryotes, protein synthesis is mainly
regulated by 4E-BP1, a repressor of 59cap-dependent translation
[40]. 4E-BP1, a downstream target of mTORC1, binds eIF4E to
inhibit protein translation. On phosphorylation, it detaches from
eIF4E to initiate protein translation [11]. With gene silencing of
4E-BP1, expressions of RC I to V were up-regulated in MEFWT.
Likewise, PTEN gene silencing showed a similar effect. The first
suggestive evidence of an involvement of translational regulation
was the observation of a drastic reduction of this translational
repressor in MEFPTEN2/2. To examine if up-regulation is peculiar
to the RCs, we measured the expressions of assorted proteins
(namely cytosolic proteins: ME 1, LDH-V and mitochondrial
proteins: HK II, UCP2, ACO2, Bcl-2 and VDAC) besides RCI to
V, following silencing of 4E-BP1. Of these, only the RCs were up-
Table 1. Inhibition of enzyme activities of respiratory
complexes.
% inhibition





Activities of respiratory complexes I to IV were inhibited by LY294002 (inhibitor
of PI3K and mTOR) and Akt inhibitor IV. Values are expressed as % inhibition
compared to untreated controls.
**p,0.01 and
#p,0.005 for n = 3.
doi:10.1371/journal.pone.0045806.t001
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Figure 5. Transcriptional Regulation. (A) Western blots of mitochondrial transcription factors The protein expressions of peroxisome proliferator-
activated receptor gamma coactivator 1-alpha (PGC-1a), nuclear respiratory factor-1 (NRF-1) and mitochondrial DNA transcription factor A (mtTFA)
were measured in MEFWT and MEFPTEN2/2. Quantitative analysis showed no significant difference between the two (inset). (B) Measurement of mRNA
by real-time PCR The mRNAs of the five subunits RCs used in our Western blot analysis were not significantly different in MEFPTEN2/2 and MEFWT with
p values shown in the accompanying table (inset). Mouse alpha 1A tubulin was used for normalization.
doi:10.1371/journal.pone.0045806.g005
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Figure 6. Parameters related to 4E-BP1. (A) Protein expressions of 4E-BP1 and p-Thr37/464E-BP1 MEFPTEN2/2 has significantly lower total 4E-BP1
but a higher ratio of phospho- relative to total- 4E-BP1 (inset). * p,0.05 for n= 3. (B) mRNA Level of 4E-BP1 The mRNA of 4E-BP1 was not different
between MEFWT and MEFPTEN2/2 with p= 0.231 for n= 3. (C) Effect of LY 294002 Hypo-phosphorylation of 4E-BP1 and p-Thr37/464E-BP1 by LY was
observed by downward band shifts in both, as indicated by arrows. (D) Effect of Akt inhibitor IV Hypo-phosphorylation of p-Thr37/46 4E-BP1 and total
4E-BP1 by Akt inhibitor IV (shown as bands of higher density, indicated by arrows) was observed but no band shift was evident. (E, F) RNA-silencing of
4E-BP1 on protein expressions of RCs in MEFWT and MEFPTEN2/2 Up-regulation of the expressions of all RCs was apparent. However, the effect was more
pronounced in MEFWT because of its higher expression of 4E-BP1 as shown in Fig. 6A. The fact that RC up-regulation was also observed in MEFPTEN2/2
suggested that there was residual 4E-BP1 in the knockout which was indeed shown in Fig. 6A. (G) Gene silencing of 4E-BP1 with and without Akt
Inhibitor IV on RC expressions in MEFWT RC expressions were significantly higher with si-4E-BP1 compared with untreated control (Lane 1) in MEFWT in
the absence or presence of Akt inhibitor IV as shown in Lanes 2 and 3, respectively (*p,0.05, # p,0.005 relative to untreated controls). Thus, it was
evident that in the absence of 4E-BP1, Akt did not affect RC expressions significantly with p values .0.05 (Fig. 6G inset, comparing Lanes 2 and 3). In
contrast, in the presence of an Akt inhibitor (AktIV), RC expressions were down-regulated when 4E-BP1 was intact (Lane 4) showing that the action of
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regulated which appeared to suggest some degree of specificity of
4E-BP1 regulation on the electron-transport proteins
Generally, the selection of mRNAs for translation is exerted at
the initiation stage with binding of elF4F complex to 59-end of
each mRNA and interaction between 39UTR binding proteins
and 4E-BPs [41]. The binding of the mRNA binding proteins of
the Pumilio (PUF) family to the 39 UTR can control mRNA
stability and translational repression [42] to provide some measure
of selectivity. Of all the Pufs indentified in yeast, Puf3p has been
shown to bind nearly exclusively to nuclear encoded mitochondrial
mRNAs [43,44]. Mitochondrial mRNAs, which essentially code
for the assembly factors of respiratory chain complexes and the
mitochondrial translation machinery are highly dependent on the
presence of Puf3 [45]. Taken together, we concluded that it is not
impossible for 4E-BP1 to regulate expressions of mitochondrial
RCs in a selective manner. However, post-translational modifica-
tion of enzyme activities cannot be ruled out as several subunits of
RCI were predicted from proteomic studies to be potentially
capable of phosphorylation, e.g. tyrosine phosphorylation of RCI
and RCV [46,47]. Transcriptional control was deemed unlikely as
there was no significant difference in the mRNAs of several
subunits of the RCs between MEFPTEN2/2 and MEFWT.
Furthermore, the protein expressions of the transcription factor
PGC-1a and its associated downstream targets, NRF-1 and
mtTFA were similar between MEFPTEN2/2 and MEFWT. Our
conclusion concurred with the report that the regulation of
mitochondrial function by mTOR is independent of transcription
[48].
In conclusion, the hyperactivated Akt confers on MEFPTEN2/2
a bioenergetic advantage by up-regulating their oxidative mito-
chondrial functions. We propose the enhanced mitochondrial
capacity in MEFPTEN2/2 is used to support their higher rate of
proliferation upon substrate availability. Increased OXPHOS has
been shown in H-Ras transformed fibroblast [49] and this bestows
a proliferative advantage to K-Ras-mediated tumorigenecity [50]
and provides energy to transformed human mesenchymal stem
cells [51]. Our hypothesis that mitochondrial respiratory capacity
is regulated by the Akt/mTOR/4E-BP1 cascade as summarized in
Fig. 7. Supporting evidence was provided using known small
molecules as inhibitors of this signaling pathway and siRNA to
knockdown PTEN or 4E-BP1 to demonstrate the link between
PTEN/Akt/mTOR/4E-BP1 signaling and protein expressions of
the electron transport respiratory complexes. Our study has
highlighted the role of 4E-BP1 in mitochondrial function in the
early-transformed cells with PTEN/Akt aberration.
Supporting Information
Figure S1 Gene silencing of 4E-BP1 on other proteins.
There was little to no effect on other proteins examined with
siRNA on 4E-BP1 in MEFWT except for Bcl-2 which was
decreased, p,0.05. In contrast, there was up-regulation of all
respiratory complexes as shown in Figure 6E and 6F.
(TIF)
Table S1 Primers used in Real-time PCR. mRNAs of
subunits (encoded by mitochondrial and nuclear DNAs) of
respiratory complexes were measured using the respective primers
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